Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital Heidelberg
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed, inoperable primary or local recurrent pancreatic cancer
Written informed consent (must be available before enrollment in the trial)
Karnofsky performance score \> 60 or ECOG-status 0/1 (at least: patient should be able to take care of himself, although daily-life activity or work is not possible)
Age ≥ 18 years
You may not be if
No clear difference between tumor edge and upper gastrointestinal tract in baseline imaging
Extensive lymphatic metastases
Disability of subject to understand character and individual consequences of the clinical trial
Distant metastases
Previous radiotherapy of the upper abdomen
Active medical implants (e.g. pacemaker, defibrillator), contradicting radiotherapy at HIT
Participation in another clinical study or observation period of competing trials, respectively
Clareo Health | Pancreatic Cancer and Carbon Ion Radiotherapy
